Aptevo Therapeutics APVO 深 沪
等待开盘 10-09 09:30:00 美东时间
1.80
-0.040
-2.17%
华盛通- 最 高1.84
- 今 开1.77
- 成交量 2.69万股
- 最 低 1.77
- 昨 收 1.84
- 总市值 325.84万
- 52周最高 29.70
- 市盈率 静 --
- 换手率 1.49%
- 52周最低 1.37
- 委 比 -81.28%
- 总股本 181.02万
- 历史最高 68020444.80
- 量 比 1.19
- 振 幅 3.80%
- 历史最低 1.37
- 每 手 1
- 风险率 8.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aptevo Expects To Enter Investigational New Drug-Enabling Studies For Its Lead Candidate APVO451 In H1 2027
Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced progress in its next-generation trispecifi...
09-24 20:13
Aptevo Shareholders Approve Equity Issuance, Reject Charter Changes
Aptevo Therapeutics ( ($APVO) ) has provided an update. On September 22, 2026, ...
09-24 04:55
Aptevo Therapeutics shares are trading lower. The company reported a 93% clinical benefit rate with its mipletamig triplet in evaluable frontline acute myeloid leukemia patients with TP53 mutations.
Aptevo Therapeutics shares are trading lower. The company reported a 93% clinical benefit rate with its mipletamig triplet in evaluable frontline acute myeloid leukemia patients with TP53 mutations.
09-03 22:27
Aptevo Reports Promising Mipletamig Data in TP53-Mutant AML
Aptevo Therapeutics ( ($APVO) ) just unveiled an announcement. On September 3, ...
09-03 20:48
Aptevo Therapeutics Q2 EPS $(5.31) Beats $(6.16) Estimate
Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(5.31) per share which beat the analyst consensus estimate of $(6.16) by 13.8 percent. This is a 96.49 percent increase over losses of $(151.20) per share from the same period last year.
08-14 20:32
Aptevo Therapeutics Raises Capital Through Warrant-Induced Financing
Aptevo Therapeutics ( ($APVO) ) has issued an update. On August 12, 2026, Aptev...
08-14 05:20
Aptevo Therapeutics shares are trading lower. The company announced exercise of existing warrants and PIPE for $4.5 million gross proceeds.
Aptevo Therapeutics shares are trading lower. The company announced exercise of existing warrants and PIPE for $4.5 million gross proceeds.
08-13 00:35
Why Ultra Clean Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Shares of Ultra Clean Holdings Inc (NASDAQ:UCTT) rose sharply in pre-market trading after the company announced the appointment of Michael Keogh as CFO. The company appoints Michael Keogh as CFO, effective Aug. 25, succeeding Sheri Savage. Ultra Clean shares jumped 6.5% to $107.50 in pre-market trad...
07-09 16:53
美股夜盘 | Republic Power涨38.76%，巨龙在线涨22.55%
Tvardi Therapeutics Inc.涨-10.80%；Dreamland涨-9.80%；有信科技涨-9.33%
07-09 08:05
Aptevo Therapeutics Partners With Niowave To Develop Up To Three Radiopharmaceutical Oncology Programs
Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform
05-27 20:09
